- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06476678
식도 병변의 새로운 양극성 고주파 절제 칼
식도 내시경 점막하 박리에서 새로운 양극성 고주파 절제 칼의 효능과 타당성을 평가하는 전향적 다기관 시험
Both Baylor St Luke's Medical Center and Mayo Scottsdale are considered endoscopic submucosal dissection (ESD) centers of excellence. The investigators at Baylor College of Medicine have previously reported our Esophageal ESD experience using the monopolar current knife. Moreover, the research team have previously reported on the clinical efficacy of the bipolar RFA knife during per-oral endoscopic myotomy (POEM) and colonic ESD. The goal of our study is to prospectively evaluate the efficacy, safety and feasibility of Esophageal ESD using a novel Bipolar-Current ESD device.
연구 개요
상세 설명
Endoscopic submucosal dissection (ESD) is a novel technique for the removal of esophageal lesions or polyps with high-risk features. ESD is minimally invasive and allows the removal of esophageal polyps without resorting to morbid surgery. The process of ESD includes marking the lesions selected for removal, followed by submucosal injection of a lifting agent, then circumferential incisions using a specialized knife followed by submucosal dissection of the entire lesion.
Traditionally, knifes utilizing monopolar current were the preferred tools for endoscopic submucosal dissection. These knifes allow accurate dissection and excellent hemostasis. However, due to monopolar current generated heat, post coagulation syndrome can be seen in up to 8 to 40 % of patients. Post coagulation syndrome present with pain, fever and leukocytosis and requires supportive treatment with IV fluid and antibiotics. In addition, for large esophageal lesions, stricturing can occur after resection due to significant scar formation resulting from the tissue healing response to electrocautery. Almost all patients with >60% of the esophageal circumference removed via monopolar knives, will develop an esophageal stricture at some point. These patients require serial esophageal dilations, and although easily managed, its development can be quite troublesome to the patient. Nevertheless, ESD is still the preferred modality for removal of these lesions since it avoids the need for morbid surgery.
Recently, a novel Bipolar RFA knife was FDA approved for endoscopic submucosal dissection. The low voltage bipolar system allows for precise cutting of submucosa and muscle using substantially less energy, thereby limiting inadvertent remote thermal effects. Additionally, it allows aggressive coagulation of vessels without dissipation of large amounts of energy, thereby allowing more targeted therapy. Moreover, with the addition of an integrated injection needle, the knife now allows injection, safe cutting and coagulation in one device, potentially supporting more efficient dissection. Ultimately, due to less thermal effect on surrounding tissue, the bipolar knife may allow for removal of large esophageal lesions without causing major esophageal stricturing.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Salmaan A Jawaid, MD
- 전화번호: 7137980950
- 이메일: Salmaan.Jawaid@bcm.edu
연구 연락처 백업
- 이름: Haydee Rochits Cueto
- 전화번호: 7137983606
- 이메일: Haydee.RochitsCueto@bcm.edu
연구 장소
-
-
Texas
-
Houston, Texas, 미국, 77030
- 모병
- Baylor College of Medicine
-
수석 연구원:
- Salmaan Jawaid, MD
-
부수사관:
- Mohamed Othman, MD
-
연락하다:
- Salmaan Jawaid, MD
- 전화번호: 713-798-0950
- 이메일: Salmaan.Jawaid@bcm.edu
-
부수사관:
- Tara Keihanian, MD
-
연락하다:
- Haydee Rochits Cueto
- 전화번호: 7137983606
- 이메일: Haydee.RochitsCueto@bcm.edu
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
All patients undergoing intended ESD of precancerous lesions will be screened by study coordinators for preliminary eligibility and those who meet the inclusion criteria will be approach individually for further discussion about the study and obtaining informed consent.
설명
Inclusion Criteria:
-
Patient is >18 years of age
-
Patient can provide informed consent
-
Patient is referred for resection of precancerous lesions meeting the following criteria:
- Mucosal based polyp
- Located gastroesophageal junction (GEJ) or proximal to GEJ
- No previous endoscopic resection attempted (EMR or ESD)
Exclusion Criteria:
- Patients with International Normalized Ratio (INR) >1.5 or Platelets <50,000
- Lesions extending past GEJ
- Subepithelial lesions
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: CASE_ONLY
- 시간 관점: PROSPECTIVE
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Treatment arm
Patients who were deemed eligible and signed the consent will undergo the removal of their esophageal precancerous lesion utilizing the novel bipolar knife during their endoscopic submucosal dissection (ESD). |
Use of Speedboat™ Ultraslim for performing endoscopic submucosal dissection of esophageal lesions. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Technical success
기간: Day 1 (procedure day)
|
Defined as the ability to perform the entire dissection (procedure) with the novel bipolar knife |
Day 1 (procedure day)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Speed of Endoscopic Submucosal Dissection
기간: During Procedure
|
The speed of endoscopic submucosal dissection as calculated by cm^2/hour |
During Procedure
|
|
Number of instruments used
기간: During Procedure
|
Logging the variable equipment utilized during the procedure |
During Procedure
|
|
Rate of muscle injury score
기간: During Procedure
|
As calculated by the Sydney Classification of Deep Mural Injury ranging from Type 0 - Type V with Type V as the most severe score. |
During Procedure
|
|
Rate of post-electrocautery syndrome
기간: 24 hours, 2 weeks, and 4 weeks
|
Define as post-procedure abdominal pain, fevers, leukocytosis |
24 hours, 2 weeks, and 4 weeks
|
|
Change in post-procedural pain score
기간: 24 hours, 2 weeks, and 4 weeks
|
As calculated by the visual analog pain scale to measure patient pain ranging from 0-10 with 10 being the most pain. |
24 hours, 2 weeks, and 4 weeks
|
|
Rate of esophageal stricturing
기간: Assessed at any follow-up post-procedure endoscopies up to 6 months
|
Calculated by number of documented occurrences post-procedure for subjects |
Assessed at any follow-up post-procedure endoscopies up to 6 months
|
|
Degree of scar formation
기간: Assessed at any follow-up post-procedure endoscopies up to 6 months
|
Scar formation that occurs in response to electrocautery |
Assessed at any follow-up post-procedure endoscopies up to 6 months
|
|
Cost of dissection
기간: During Procedure
|
As calculated upon review of devices used during dissection procedure |
During Procedure
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .